(Post-pandemic Era)-Global Insulin Delivery System Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
- Report Code : XYZ2157162
- Published On: Dec, 2020
- Category : Medical Devices
- Pages : 124
-
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research team published a report for global Insulin Delivery System market in this environment.
In terms of revenue, this research report indicated that the global Insulin Delivery System market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Insulin Delivery System industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The BD aims at producing XX Insulin Delivery System in 2020, with XX % production to take place in global market, Novo Nordisk accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Insulin Delivery System Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Insulin Delivery System Market
BD
Novo Nordisk
Sanofi
Eli Lilly
Medtronic
Animas
Beta Bionics
Cellnovo
Copernicus
Dance Biopharm
Debiotech
InsuJet
Insulet
MannKind
Owen Mumford
Roche
SHL
SOOIL
Tandem Diabetes Care
Valeritas
West Pharma
Ypsomed
Major Type of Insulin Delivery System Covered in Research report:
Insulin Syringes
Insulin PumpS
Insulin Pens
Application Segments Covered in Research report:
Hospitals
Specialty Diabetic Clinics
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
-
With tables and figures helping analyze worldwide (Post pandemic Era) Global Insulin Delivery System market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Insulin Delivery System Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope1.1 Product Details and Introduction
1.1.1 Insulin Syringes -Product Introduction and Major Manufacturers
1.1.2 Insulin PumpS -Product Introduction and Major Manufacturers
1.1.3 Insulin Pens -Product Introduction and Major Manufacturers1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Insulin Delivery System Market Assessment, by Segmentation2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis3.1 China Insulin Delivery System Market
3.1.1 Top Companies leading Insulin Delivery System Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Insulin Delivery System Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)3.2 EU Insulin Delivery System Market
3.2.1 Top Companies leading Insulin Delivery System Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Insulin Delivery System Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)3.3 USA Insulin Delivery System Market
3.3.1 Top Companies leading Insulin Delivery System Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Insulin Delivery System Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)3.4 Japan Insulin Delivery System Market
3.4.1 Top Companies leading Insulin Delivery System Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Insulin Delivery System Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)3.5 India Insulin Delivery System Market
3.5.1 Top Companies leading Insulin Delivery System Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Insulin Delivery System Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)3.6 Southeast Asia Insulin Delivery System Market
3.6.1 Top Companies leading Insulin Delivery System Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Insulin Delivery System Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Insulin Delivery System Market
3.7.1 Top Companies leading Insulin Delivery System Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Insulin Delivery System Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)4.1 Insulin Delivery System Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream4.2 COVID-19 Impact on Insulin Delivery System Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)5.1 Global Insulin Delivery System Sales and Growth Rate (2021-2026)
5.2 Global Insulin Delivery System Sales Value and Growth Rate (2021-2026)
6 Insulin Delivery System Competitive Analysis6.1 BD
6.1.1 BD Company Profiles
6.1.2 BD Product Introduction
6.1.3 BD Insulin Delivery System Production, Revenue (2015-2020)
6.1.4 SWOT Analysis6.2 Novo Nordisk
6.2.1 Novo Nordisk Company Profiles
6.2.2 Novo Nordisk Product Introduction
6.2.3 Novo Nordisk Insulin Delivery System Production, Revenue (2015-2020)
6.2.4 SWOT Analysis6.3 Sanofi
6.3.1 Sanofi Company Profiles
6.3.2 Sanofi Product Introduction
6.3.3 Sanofi Insulin Delivery System Production, Revenue (2015-2020)
6.3.4 SWOT Analysis6.4 Eli Lilly
6.4.1 Eli Lilly Company Profiles
6.4.2 Eli Lilly Product Introduction
6.4.3 Eli Lilly Insulin Delivery System Production, Revenue (2015-2020)
6.4.4 SWOT Analysis6.5 Medtronic
6.5.1 Medtronic Company Profiles
6.5.2 Medtronic Product Introduction
6.5.3 Medtronic Insulin Delivery System Production, Revenue (2015-2020)
6.5.4 SWOT Analysis6.6 Animas
6.6.1 Animas Company Profiles
6.6.2 Animas Product Introduction
6.6.3 Animas Insulin Delivery System Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Beta Bionics
6.7.1 Beta Bionics Company Profiles
6.7.2 Beta Bionics Product Introduction
6.7.3 Beta Bionics Insulin Delivery System Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Cellnovo
6.8.1 Cellnovo Company Profiles
6.8.2 Cellnovo Product Introduction
6.8.3 Cellnovo Insulin Delivery System Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Copernicus
6.9.1 Copernicus Company Profiles
6.9.2 Copernicus Product Introduction
6.9.3 Copernicus Insulin Delivery System Production, Revenue (2015-2020)
6.9.4 SWOT Analysis6.10 Dance Biopharm
6.10.1 Dance Biopharm Company Profiles
6.10.2 Dance Biopharm Product Introduction
6.10.3 Dance Biopharm Insulin Delivery System Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
6.11 Debiotech
6.12 InsuJet
6.13 Insulet
6.14 MannKind
6.15 Owen Mumford
6.16 Roche
6.17 SHL
6.18 SOOIL
6.19 Tandem Diabetes Care6.20 Valeritas
6.21 West Pharma
6.22 Ypsomed
7 Conclusion
-
The (Post pandemic Era) Global Insulin Delivery System Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the (Post pandemic Era) Global Insulin Delivery System Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
(Post pandemic Era) Global Insulin Delivery System has a wide range of applications, including
In recent years, the (Post pandemic Era) Global Insulin Delivery System Market has grown at an incredible rate. From 2024 to 2029, the market is expected to grow at a CAGR of yy%.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the (Post pandemic Era) Global Insulin Delivery System Market as well as its distribution among its players
The latest version of the (Post pandemic Era) Global Insulin Delivery System Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.
